Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort
- PMID: 31433400
- PMCID: PMC6649944
- DOI: 10.1093/rap/rky036
Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort
Figures
References
-
- Yahya F, Gaffney K, Hamilton L. et al. Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort. Rheumatology 2018;57:619–24. - PubMed
-
- van der Horst-Bruinsma IE, Zack DJ, Szumski A, Koenig AS.. Female patients with ankylosing spondylitis: analysis of the impact of gender across treatment studies. Ann Rheum Dis 2013;72:1221–4. - PubMed
-
- Brophy S, Taylor G, Blake D, Calin A.. The interrelationship between sex, susceptibility factors, and outcome in ankylosing spondylitis and its associated disorders including inflammatory bowel disease, psoriasis, and iritis. J Rheumatol 2003;30:2054–8. - PubMed
LinkOut - more resources
Full Text Sources